These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 11906665

  • 1. Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
    Gelatt KN, MacKay EO.
    Vet Ophthalmol; 2001 Dec; 4(4):283-8. PubMed ID: 11906665
    [Abstract] [Full Text] [Related]

  • 2. Effect of single and multiple doses of 0.2% brimonidine tartrate in the glaucomatous Beagle.
    Gelatt KN, MacKay EO.
    Vet Ophthalmol; 2002 Dec; 5(4):253-62. PubMed ID: 12445295
    [Abstract] [Full Text] [Related]

  • 3. Effect of different dose schedules of travoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
    Gelatt KN, MacKay EO.
    Vet Ophthalmol; 2004 Dec; 7(1):53-7. PubMed ID: 14738508
    [Abstract] [Full Text] [Related]

  • 4. Effect of different dose schedules of bimatoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
    Gelatt KN, Mackay EO.
    J Ocul Pharmacol Ther; 2002 Dec; 18(6):525-34. PubMed ID: 12537679
    [Abstract] [Full Text] [Related]

  • 5. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs.
    Gelatt KN, MacKay EO.
    Vet Ophthalmol; 2001 Mar; 4(1):61-7. PubMed ID: 11397321
    [Abstract] [Full Text] [Related]

  • 6. Effect of different dose schedules of 0.15% unoprostone isopropyl on intraocular pressure and pupil size in the glaucomatous beagle.
    Gelatt KN, Mackay EO, Dashiell T, Biken A.
    J Ocul Pharmacol Ther; 2004 Oct; 20(5):411-20. PubMed ID: 15650516
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of latanoprost and latanoprostene bunod on intraocular pressure and pupil size in ophthalmologically normal Beagle dogs.
    Desai SJ, Pumphrey SA, Koethe B.
    Vet Ophthalmol; 2022 Jul; 25(4):282-290. PubMed ID: 35247289
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of topically administered netarsudil-latanoprost fixed dose combination (FDC; Rocklatan™) in normal and glaucomatous dogs with ADAMTS10-open-angle glaucoma (ADAMTS10-OAG).
    Leary KA, Steibel JP, Harman CD, Anderson AL, Komáromy AM.
    Vet Ophthalmol; 2021 Nov; 24(6):610-619. PubMed ID: 34085750
    [Abstract] [Full Text] [Related]

  • 9. Comparison of intraocular pressure lowering effect of once daily morning vs evening dosing of latanoprost/timolol maleate combination.
    Takmaz T, Aşik S, Kürkçüoğlu P, Gurdal C, Can I.
    Eur J Ophthalmol; 2008 Nov; 18(1):60-5. PubMed ID: 18203086
    [Abstract] [Full Text] [Related]

  • 10. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma.
    Sponsel WE, Paris G, Trigo Y, Pena M.
    Am J Ophthalmol; 2002 Oct; 134(4):552-9. PubMed ID: 12383812
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs.
    Plummer CE, MacKay EO, Gelatt KN.
    Vet Ophthalmol; 2006 Oct; 9(4):245-9. PubMed ID: 16771760
    [Abstract] [Full Text] [Related]

  • 12. Effect of Coherin™ on intraocular pressure, pupil size and heart rate in the glaucomatous Beagle: a pilot study.
    MacKay EO, Gelatt KN.
    Vet Ophthalmol; 2013 May; 16(3):198-203. PubMed ID: 22853548
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects.
    Araie M, Sforzolini BS, Vittitow J, Weinreb RN.
    Adv Ther; 2015 Nov; 32(11):1128-39. PubMed ID: 26563323
    [Abstract] [Full Text] [Related]

  • 14. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
    Mastropasqua L, Carpineto P, Ciancaglini M, Gallenga PE.
    Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
    [Abstract] [Full Text] [Related]

  • 15. A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components.
    Diestelhorst M, Larsson LI, European-Canadian Latanoprost Fixed Combination Study Group.
    Ophthalmology; 2006 Jan; 113(1):70-6. PubMed ID: 16263174
    [Abstract] [Full Text] [Related]

  • 16. Comparison of two- and three-times-daily topical ophthalmic application of 0.005% latanoprost solution in clinically normal dogs.
    Tofflemire KL, Whitley EM, Allbaugh RA, Ben-Shlomo G, Robinson CC, Overton TL, Thiessen CE, Evans EA, Griggs AN, Adelman SA, Ludwig AL, Jens JK, Ellinwood NM, Peterson CS, Whitley RD.
    Am J Vet Res; 2015 Jul; 76(7):625-31. PubMed ID: 26111092
    [Abstract] [Full Text] [Related]

  • 17. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D.
    Eur J Ophthalmol; 2007 Jul; 17(2):183-90. PubMed ID: 17415690
    [Abstract] [Full Text] [Related]

  • 18. Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients.
    Liu CJ, Ko YC, Cheng CY, Chiu AW, Chou JC, Hsu WM, Liu JH.
    Ophthalmology; 2002 Dec; 109(12):2241-7. PubMed ID: 12466165
    [Abstract] [Full Text] [Related]

  • 19. Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma.
    Konstas AG, Maltezos AC, Gandi S, Hudgins AC, Stewart WC.
    Am J Ophthalmol; 1999 Jul; 128(1):15-20. PubMed ID: 10482089
    [Abstract] [Full Text] [Related]

  • 20. Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States.
    Camras CB, Sheu WP, United States Latanoprost-Brimonidine Study Group.
    J Glaucoma; 2005 Apr; 14(2):161-7. PubMed ID: 15741820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.